Research ArticleOriginal Research
GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting
Laura C. Coates, Nadia Corp, Danielle A. van der Windt, Enrique R. Soriano and Arthur Kavanaugh
The Journal of Rheumatology Supplement June 2021, 97 65-66; DOI: https://doi.org/10.3899/jrheum.201681
Laura C. Coates
1L.C. Coates, MB ChB, PhD, National Institute for Health Research Clinician Scientist, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK;
Nadia Corp
2N. Corp, PhD, D.A. van der Windt, PhD, Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Staffordshire, UK;
Danielle A. van der Windt
2N. Corp, PhD, D.A. van der Windt, PhD, Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Staffordshire, UK;
Enrique R. Soriano
3E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, and University Institute Hospital Italiano de Buenos Aires, Buenos Aires, Argentina;
Arthur Kavanaugh
4A. Kavanaugh, MD, Division of Rheumatology Allergy and Immunology, University of California, San Diego, La Jolla, California, USA.
References
- 1.↵
- Coates LC,
- Kavanaugh A,
- Mease PJ,
- Soriano ER,
- Acosta-Felquer M,
- Armstrong AW, et al
- 2.↵
- Kavanaugh A,
- Coates LC,
- van der Windt DA,
- Corp N,
- Soriano ER
- 3.↵
- Guyatt GH,
- Oxman AD,
- Vist GE,
- Kunz R,
- Falck-Ytter Y,
- Alonso-Coello P, et al
In this issue
GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting
Laura C. Coates, Nadia Corp, Danielle A. van der Windt, Enrique R. Soriano, Arthur Kavanaugh
The Journal of Rheumatology Supplement Jun 2021, 97 65-66; DOI: 10.3899/jrheum.201681